EFDID: 90112EFD: View Filing

Issuer: Reven Pharmaceuticals, Inc. (0001556231) - D

Accession: 0000897069-14-000156 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001556231
  • Entity Name:
    Reven Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    FLORIDA
  • Year of Inc:
    Over 5 years ago
  • Address:
    4411 BEE RIDGE ROAD
    SUITE 285
    SARASOTA, FL 34233
  • Persons:
    Related Persons 3
    Peter B. Lange
    Executive OfficerDirector
    Brian Denomme
    Executive OfficerDirector
    Michael Handley
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    02/19/2014
  • First Sale Date:
  • Offering Amount:
    $7,000,000
  • Amount Sold:
    $0
  • Amount Remaining:
    $7,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Futures Investment Company 42402 None None IN
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Reven Pharmaceuticals, Inc.Peter B. LangePeter B. LangePresident2014-02-19
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Feb. 18, 2015 90112: 0000897069-15-000162 Reven Pharmaceuticals, Inc.
Offer Amount: $7,000,000
Amount Sold: $4,440,594
Remaining: $2,559,406
D Feb. 19, 2014 90112: 0000897069-14-000156 Reven Pharmaceuticals, Inc.
Offer Amount: $7,000,000
Remaining: $7,000,000